Kevin Manemann, chief executive, Providence Southern California, completes a two-part interview with Ora Gordon, MD, about exciting developments in the field of genetic research. Part two features:
- How cancers grow at a different pace
- How molecular vulnerabilities of a tumor can determine how we treat a specific cancer
Part one can be viewed by scrolling down to the November issue of Clinical Connections.